Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 21;9(5):2498-2508.
doi: 10.1039/c8ra10424g. eCollection 2019 Jan 18.

Synthesis and biological evaluation of 2,2-dimethylbenzopyran derivatives as potent neuroprotection agents

Fangyu Du  1 , Qifan Zhou  1 , Xiaoxiao Fu  2 , Yajie Shi  1 , Yuanguang Chen  1 , Wuhong Fang  1 , Jingyu Yang  2 , Guoliang Chen  1
Affiliations

Synthesis and biological evaluation of 2,2-dimethylbenzopyran derivatives as potent neuroprotection agents

Fangyu Du et al. RSC Adv. .

Abstract

The development of novel neuroprotection agents is of great significance for the treatment of ischemic stroke. In this study, a series of compounds comprising 2,2-dimethylbenzopyran groups and cinnamic acid groups have been synthesized. Preferential combination principles and bioisostere that improved the neuroprotective effect of the compounds were identified for this series via biological activity assay in vitro. Meanwhile, a functional reversal group of the acrylamide amide resulted in the most active compounds. Among them, BN-07 significantly improved the morphology of neurons and obviously increased cell survival rate of primary neurons induced by oxygen glucose deprivation (OGD), superior to clinically used anti-ischemic stroke drug edaravone (Eda). Overall, our findings may provide an alternative strategy for the design of novel anti-ischemic stroke agents with more potency than Eda.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Structures of 2,2-dimethylbenzopyran derivatives and edaravone.
Scheme 1
Scheme 1. Synthesis of BA compounds. Reaction and conditions: (a) CuCl, CaCl2, conc. HCl, r.t., 1 h; (b) CH2(COOH)2, pyridine, piperidine, toluene, reflux, 12 h; (c) K2CO3, KI, PEG 600, acetone, reflux, 72 h; (d) diphenyl ether, reflux, 2 h; (e) 50% NaOH, ethanol, reflux, 12 h; (f) EDCI, HOBt, THF, r.t., 14 h.
Scheme 2
Scheme 2. Synthesis of BN compounds. Reaction and conditions: (a) DBU, CuCl, acetonitrile, r.t., 4 h; (b) PhNMe2, reflux, 2 h; (c) CH2(COOH)2, pyridine, piperidine, toluene, reflux, 12 h; (d) HX-Ar, EDCI, HOBt, THF, r.t., 14 h.
Fig. 2
Fig. 2. Purity identification of rat primary cortical neurons.
Fig. 3
Fig. 3. Morphology of OGD neurons after administration of BN-07.
See this image and copyright information in PMC

References

    1. Go A. S. Mozaffarian D. Roger V. L. Benjamin E. J. Berry J. D. Borden W. B. Bravata D. M. Dai S. Ford E. S. Fox C. S. Franco S. Fullerton H. J. Gillespie C. Hailpern S. M. Heit J. A. Howard V. J. Huffman M. D. Kissela B. M. Kittner S. J. Lackland D. T. Lichtman J. H. Lisabeth L. D. Magid D. Marcus G. M. Marelli A. Matchar D. B. McGuire D. K. Mohler E. R. Moy C. S. Mussolino M. E. Nichol G. Paynter N. P. Schreiner P. J. Sorlie P. D. Stein J. Turan T. N. Virani S. S. Wong N. D. Woo D. Turner M. B. Circulation. 2013;127:e6–e245. - PMC - PubMed
    1. Pandian J. D. Padma V. Vijaya P. Sylaja P. N. Murthy J. M. Int. J. Stroke. 2007;2:17–26. doi: 10.1111/j.1747-4949.2007.00089.x. - DOI - PubMed
    1. Chen X. Wang K. Acta Pharm. Sin. B. 2016;6:522–530. doi: 10.1016/j.apsb.2016.06.013. - DOI - PMC - PubMed
    1. Kilic I. D. Hakeem A. Marmagkiolis K. Paixao A. Grunwald I. Mutlu D. Abou-Sherif S. Gundogdu B. Kulaksizoglu S. Ates I. Wholey M. Goktekin O. Cilingiroglu M. Cardiovasc. Revasc. Med. 2018 doi: 10.1016/j.carrev.2018.07.010. - DOI
    1. Mu Z. H. Jiang Z. Lin X. J. Wang L. P. Xi Y. Zhang Z. J. Wang Y. T. Yang G. Y. CNS Neurosci. Ther. 2016;22:316–324. doi: 10.1111/cns.12500. - DOI - PMC - PubMed